Average Co-Inventor Count = 5.58
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxo Group Limited (9 from 1,168 patents)
2. Smithkline Beecham Corporation (3 from 2,198 patents)
12 patents:
1. 8207331 - Benzazepine derivatives for the treatment of neurological disorders
2. 7888347 - Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists
3. 7799773 - Benzazepine derivatives for the treatment of neurological disorders
4. 7452906 - Pyridine derivatives as Raf kinase inhibitors
5. 7432289 - 5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
6. 7396843 - 5'-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
7. 7348339 - Imidazopyridine derivatives as kinase inhibitors
8. 7309800 - Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
9. 7297693 - Nitrogen-containing heterocyclic compounds and their use as Raf inhibitors
10. 7183297 - Biphenyl-derivatives as p38-kinase inhibitors
11. 7151118 - Biphenylcarboxylic amide derivatives as p38-kinase inhibitors
12. 6861441 - Use of EP4 receptor ligands in the treatment of neuropathic pain and colon cancer